These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 2382234

  • 1. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Jolliffe LK, Colvin RB.
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Bedle M, Colvin RB.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients.
    Wee SL, Stroka DM, Preffer FI, Jolliffe LK, Colvin RB, Cosimi AB.
    Transplantation; 1992 Mar; 53(3):501-7. PubMed ID: 1532265
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.
    Transplantation; 1997 Apr 27; 63(8):1087-95. PubMed ID: 9133469
    [Abstract] [Full Text] [Related]

  • 13. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients.
    Powelson JA, Knowles RW, Delmonico FL, Kawai T, Mourad G, Preffer FK, Colvin RB, Cosimi AB.
    Transplantation; 1994 Mar 27; 57(6):788-93. PubMed ID: 7908767
    [Abstract] [Full Text] [Related]

  • 14. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB.
    J Heart Transplant; 1989 Mar 27; 8(5):371-80. PubMed ID: 2529358
    [Abstract] [Full Text] [Related]

  • 15. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May 15; 63(9):1243-51. PubMed ID: 9158016
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG, Huang EH, Bergese SD, Sedmak DD, Birmingham DJ, Ohye RG, VanBuskirk AM.
    J Heart Lung Transplant; 1997 Sep 15; 16(9):889-904. PubMed ID: 9322138
    [Abstract] [Full Text] [Related]

  • 19. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).
    Henrickson M, Reid J, Bellet JS, Sawchuk SS, Hirsch R.
    Transplantation; 1995 Oct 27; 60(8):828-35. PubMed ID: 7482743
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov 27; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.